WEBVTT
Kind: captions
Language: en

00:00:11.330 --> 00:00:14.270 

skin<00:00:12.330> neoplasms<00:00:13.049> also<00:00:13.469> known<00:00:13.650> as<00:00:13.799> skin<00:00:14.099> cancer

00:00:14.270 --> 00:00:14.280 
skin neoplasms also known as skin cancer

00:00:14.280 --> 00:00:16.340 
skin neoplasms also known as skin cancer
your<00:00:14.790> skin<00:00:15.089> growths<00:00:15.330> with<00:00:15.570> different<00:00:15.990> causes

00:00:16.340 --> 00:00:16.350 
your skin growths with different causes

00:00:16.350 --> 00:00:18.349 
your skin growths with different causes
and<00:00:16.500> varying<00:00:16.800> degrees<00:00:16.830> of<00:00:17.190> malignancy<00:00:17.910> the

00:00:18.349 --> 00:00:18.359 
and varying degrees of malignancy the

00:00:18.359 --> 00:00:20.300 
and varying degrees of malignancy the
three<00:00:18.600> most<00:00:18.779> common<00:00:18.869> malignant<00:00:19.619> skin<00:00:19.890> cancers

00:00:20.300 --> 00:00:20.310 
three most common malignant skin cancers

00:00:20.310 --> 00:00:22.550 
three most common malignant skin cancers
are<00:00:20.580> basal<00:00:21.029> cell<00:00:21.210> cancer<00:00:21.600> skirmished<00:00:22.350> cell

00:00:22.550 --> 00:00:22.560 
are basal cell cancer skirmished cell

00:00:22.560 --> 00:00:24.679 
are basal cell cancer skirmished cell
cancer<00:00:22.920> and<00:00:23.130> melanoma<00:00:23.519> each<00:00:24.180> of<00:00:24.359> which<00:00:24.539> is

00:00:24.679 --> 00:00:24.689 
cancer and melanoma each of which is

00:00:24.689 --> 00:00:26.269 
cancer and melanoma each of which is
named<00:00:24.900> after<00:00:25.080> the<00:00:25.320> type<00:00:25.500> of<00:00:25.529> skin<00:00:25.980> cell<00:00:26.250> from

00:00:26.269 --> 00:00:26.279 
named after the type of skin cell from

00:00:26.279 --> 00:00:28.460 
named after the type of skin cell from
which<00:00:26.430> it<00:00:26.699> arises<00:00:26.810> skin<00:00:27.810> cancer<00:00:28.230> symptoms

00:00:28.460 --> 00:00:28.470 
which it arises skin cancer symptoms

00:00:28.470 --> 00:00:30.830 
which it arises skin cancer symptoms
there<00:00:29.160> are<00:00:29.429> a<00:00:29.460> variety<00:00:29.760> of<00:00:30.119> different<00:00:30.210> skin

00:00:30.830 --> 00:00:30.840 
there are a variety of different skin

00:00:30.840 --> 00:00:33.440 
there are a variety of different skin
cancer<00:00:31.260> symptoms<00:00:31.500> these<00:00:32.430> include<00:00:32.820> changes<00:00:33.300> in

00:00:33.440 --> 00:00:33.450 
cancer symptoms these include changes in

00:00:33.450 --> 00:00:35.360 
cancer symptoms these include changes in
the<00:00:33.540> skin<00:00:33.780> that<00:00:33.989> do<00:00:34.140> not<00:00:34.290> heal<00:00:34.559> altering<00:00:35.250> in

00:00:35.360 --> 00:00:35.370 
the skin that do not heal altering in

00:00:35.370 --> 00:00:37.790 
the skin that do not heal altering in
the<00:00:35.460> skin<00:00:35.730> discolored<00:00:36.510> skin<00:00:36.660> and<00:00:37.050> changes<00:00:37.649> in

00:00:37.790 --> 00:00:37.800 
the skin discolored skin and changes in

00:00:37.800 --> 00:00:40.130 
the skin discolored skin and changes in
existing<00:00:37.950> laws<00:00:38.430> such<00:00:38.969> as<00:00:39.000> jagged<00:00:39.480> edges<00:00:39.660> to

00:00:40.130 --> 00:00:40.140 
existing laws such as jagged edges to

00:00:40.140 --> 00:00:41.569 
existing laws such as jagged edges to
the<00:00:40.260> mole<00:00:40.440> and<00:00:40.590> enlargement<00:00:41.219> of<00:00:41.309> the<00:00:41.399> mole

00:00:41.569 --> 00:00:41.579 
the mole and enlargement of the mole

00:00:41.579 --> 00:00:43.940 
the mole and enlargement of the mole
skin<00:00:42.270> cancer<00:00:42.690> treatment<00:00:43.110> treatment<00:00:43.860> is

00:00:43.940 --> 00:00:43.950 
skin cancer treatment treatment is

00:00:43.950 --> 00:00:46.160 
skin cancer treatment treatment is
dependent<00:00:44.460> on<00:00:44.550> type<00:00:44.820> of<00:00:44.850> cancer<00:00:45.329> location<00:00:46.050> of

00:00:46.160 --> 00:00:46.170 
dependent on type of cancer location of

00:00:46.170 --> 00:00:47.720 
dependent on type of cancer location of
the<00:00:46.260> cancer<00:00:46.440> age<00:00:46.800> of<00:00:47.070> the<00:00:47.190> patient<00:00:47.579> and

00:00:47.720 --> 00:00:47.730 
the cancer age of the patient and

00:00:47.730 --> 00:00:49.490 
the cancer age of the patient and
whether<00:00:48.149> the<00:00:48.300> cancer<00:00:48.510> is<00:00:48.809> primary<00:00:49.289> or

00:00:49.490 --> 00:00:49.500 
whether the cancer is primary or

00:00:49.500 --> 00:00:51.680 
whether the cancer is primary or
recurrence<00:00:50.000> treatment<00:00:51.000> is<00:00:51.090> also<00:00:51.270> determined

00:00:51.680 --> 00:00:51.690 
recurrence treatment is also determined

00:00:51.690 --> 00:00:54.290 
recurrence treatment is also determined
by<00:00:51.899> the<00:00:52.050> specific<00:00:52.350> type<00:00:52.890> of<00:00:52.920> cancer<00:00:53.250> for<00:00:54.239> a

00:00:54.290 --> 00:00:54.300 
by the specific type of cancer for a

00:00:54.300 --> 00:00:56.029 
by the specific type of cancer for a
small<00:00:54.570> base<00:00:54.780> will<00:00:54.960> cell<00:00:55.170> cancer<00:00:55.559> in<00:00:55.739> a<00:00:55.829> young

00:00:56.029 --> 00:00:56.039 
small base will cell cancer in a young

00:00:56.039 --> 00:00:57.889 
small base will cell cancer in a young
person<00:00:56.460> the<00:00:56.760> treatment<00:00:57.180> with<00:00:57.329> the<00:00:57.360> best<00:00:57.629> cure

00:00:57.889 --> 00:00:57.899 
person the treatment with the best cure

00:00:57.899 --> 00:01:00.830 
person the treatment with the best cure
rate<00:00:58.109> mass<00:00:58.559> surgery<00:00:58.980> or<00:00:59.190> CCPD<00:00:59.910> MA<00:01:00.210> might<00:01:00.660> be

00:01:00.830 --> 00:01:00.840 
rate mass surgery or CCPD MA might be

00:01:00.840 --> 00:01:02.930 
rate mass surgery or CCPD MA might be
indicated<00:01:01.410> in<00:01:01.500> the<00:01:02.190> case<00:01:02.370> of<00:01:02.579> an<00:01:02.670> elderly

00:01:02.930 --> 00:01:02.940 
indicated in the case of an elderly

00:01:02.940 --> 00:01:04.850 
indicated in the case of an elderly
frail<00:01:03.270> man<00:01:03.600> with<00:01:03.780> multiple<00:01:03.960> complicating

00:01:04.850 --> 00:01:04.860 
frail man with multiple complicating

00:01:04.860 --> 00:01:06.920 
frail man with multiple complicating
medical<00:01:05.250> problems<00:01:05.700> a<00:01:05.850> difficult<00:01:06.479> to<00:01:06.540> excise

00:01:06.920 --> 00:01:06.930 
medical problems a difficult to excise

00:01:06.930 --> 00:01:08.929 
medical problems a difficult to excise
basal<00:01:07.350> cell<00:01:07.530> cancer<00:01:07.950> of<00:01:08.130> the<00:01:08.250> nose<00:01:08.460> might

00:01:08.929 --> 00:01:08.939 
basal cell cancer of the nose might

00:01:08.939 --> 00:01:11.060 
basal cell cancer of the nose might
warrant<00:01:09.180> radiation<00:01:09.780> therapy<00:01:10.229> slightly<00:01:10.860> lower

00:01:11.060 --> 00:01:11.070 
warrant radiation therapy slightly lower

00:01:11.070 --> 00:01:13.039 
warrant radiation therapy slightly lower
cure<00:01:11.369> rate<00:01:11.610> or<00:01:11.850> no<00:01:12.119> treatment<00:01:12.420> at<00:01:12.659> all

00:01:13.039 --> 00:01:13.049 
cure rate or no treatment at all

00:01:13.049 --> 00:01:15.649 
cure rate or no treatment at all
topical<00:01:13.979> chemotherapy<00:01:14.670> might<00:01:14.970> be<00:01:15.150> indicated

00:01:15.649 --> 00:01:15.659 
topical chemotherapy might be indicated

00:01:15.659 --> 00:01:17.359 
topical chemotherapy might be indicated
for<00:01:15.689> large<00:01:16.049> superficial<00:01:16.830> basal<00:01:17.189> cell

00:01:17.359 --> 00:01:17.369 
for large superficial basal cell

00:01:17.369 --> 00:01:19.940 
for large superficial basal cell
carcinoma<00:01:18.150> for<00:01:18.420> good<00:01:18.659> cosmetic<00:01:19.259> outcome<00:01:19.680> or

00:01:19.940 --> 00:01:19.950 
carcinoma for good cosmetic outcome or

00:01:19.950 --> 00:01:21.590 
carcinoma for good cosmetic outcome or
as<00:01:20.100> it<00:01:20.250> might<00:01:20.400> be<00:01:20.580> inadequate<00:01:20.850> for<00:01:21.270> invasive

00:01:21.590 --> 00:01:21.600 
as it might be inadequate for invasive

00:01:21.600 --> 00:01:24.109 
as it might be inadequate for invasive
nodular<00:01:22.170> basal<00:01:22.560> cell<00:01:22.770> carcinoma<00:01:23.549> or<00:01:23.670> invasive

00:01:24.109 --> 00:01:24.119 
nodular basal cell carcinoma or invasive

00:01:24.119 --> 00:01:27.080 
nodular basal cell carcinoma or invasive
squamous<00:01:24.689> cell<00:01:25.110> carcinoma<00:01:25.939> citation<00:01:26.939> needed

00:01:27.080 --> 00:01:27.090 
squamous cell carcinoma citation needed

00:01:27.090 --> 00:01:29.840 
squamous cell carcinoma citation needed
in<00:01:27.420> general<00:01:28.409> melanoma<00:01:29.040> is<00:01:29.250> poorly<00:01:29.610> responsive

00:01:29.840 --> 00:01:29.850 
in general melanoma is poorly responsive

00:01:29.850 --> 00:01:32.060 
in general melanoma is poorly responsive
to<00:01:30.299> radiation<00:01:30.840> or<00:01:30.930> chemotherapy<00:01:31.229> for

00:01:32.060 --> 00:01:32.070 
to radiation or chemotherapy for

00:01:32.070 --> 00:01:34.280 
to radiation or chemotherapy for
low-risk<00:01:32.460> disease<00:01:32.840> radiation<00:01:33.840> therapy

00:01:34.280 --> 00:01:34.290 
low-risk disease radiation therapy

00:01:34.290 --> 00:01:36.350 
low-risk disease radiation therapy
external<00:01:34.979> beam<00:01:35.130> radiotherapy<00:01:35.460> or<00:01:35.970> booky

00:01:36.350 --> 00:01:36.360 
external beam radiotherapy or booky

00:01:36.360 --> 00:01:38.870 
external beam radiotherapy or booky
therapy<00:01:36.810> topical<00:01:37.500> chemotherapy<00:01:38.189> in<00:01:38.369> LaMotta

00:01:38.870 --> 00:01:38.880 
therapy topical chemotherapy in LaMotta

00:01:38.880 --> 00:01:40.789 
therapy topical chemotherapy in LaMotta
a<00:01:38.970> five-floor<00:01:39.420> aerosol<00:01:39.930> and<00:01:40.140> cryotherapy

00:01:40.789 --> 00:01:40.799 
a five-floor aerosol and cryotherapy

00:01:40.799 --> 00:01:43.190 
a five-floor aerosol and cryotherapy
freezing<00:01:41.759> the<00:01:41.850> cancer<00:01:42.210> off<00:01:42.450> can<00:01:42.899> provide

00:01:43.190 --> 00:01:43.200 
freezing the cancer off can provide

00:01:43.200 --> 00:01:45.260 
freezing the cancer off can provide
adequate<00:01:43.500> control<00:01:44.009> of<00:01:44.130> the<00:01:44.220> disease<00:01:44.369> both

00:01:45.260 --> 00:01:45.270 
adequate control of the disease both

00:01:45.270 --> 00:01:47.480 
adequate control of the disease both
however<00:01:45.930> may<00:01:46.380> have<00:01:46.560> lower<00:01:46.740> overall<00:01:47.100> cure

00:01:47.480 --> 00:01:47.490 
however may have lower overall cure

00:01:47.490 --> 00:01:49.639 
however may have lower overall cure
rates<00:01:47.700> than<00:01:47.880> certain<00:01:48.149> type<00:01:48.360> of<00:01:48.390> surgery<00:01:48.840> other

00:01:49.639 --> 00:01:49.649 
rates than certain type of surgery other

00:01:49.649 --> 00:01:51.050 
rates than certain type of surgery other
modalities<00:01:50.340> of<00:01:50.369> treatment<00:01:50.520> such<00:01:51.030> as

00:01:51.050 --> 00:01:51.060 
modalities of treatment such as

00:01:51.060 --> 00:01:53.090 
modalities of treatment such as
photodynamic<00:01:51.689> therapy<00:01:52.100> topical

00:01:53.090 --> 00:01:53.100 
photodynamic therapy topical

00:01:53.100 --> 00:01:55.399 
photodynamic therapy topical
chemotherapy<00:01:53.759> electro<00:01:54.540> desiccation<00:01:55.229> and

00:01:55.399 --> 00:01:55.409 
chemotherapy electro desiccation and

00:01:55.409 --> 00:01:57.350 
chemotherapy electro desiccation and
curated<00:01:55.979> can<00:01:56.159> be<00:01:56.280> found<00:01:56.520> in<00:01:56.700> the<00:01:56.759> discussions

00:01:57.350 --> 00:01:57.360 
curated can be found in the discussions

00:01:57.360 --> 00:01:59.389 
curated can be found in the discussions
and<00:01:57.540> basal<00:01:58.049> cell<00:01:58.259> carcinoma<00:01:58.920> and<00:01:59.070> squamous

00:01:59.389 --> 00:01:59.399 
and basal cell carcinoma and squamous

00:01:59.399 --> 00:02:01.910 
and basal cell carcinoma and squamous
cell<00:01:59.909> carcinoma<00:02:00.600> mouse<00:02:01.079> micrographic

00:02:01.910 --> 00:02:01.920 
cell carcinoma mouse micrographic

00:02:01.920 --> 00:02:03.950 
cell carcinoma mouse micrographic
surgery<00:02:01.950> mouse<00:02:02.700> surgery<00:02:03.180> is<00:02:03.390> a<00:02:03.450> technique

00:02:03.950 --> 00:02:03.960 
surgery mouse surgery is a technique

00:02:03.960 --> 00:02:05.660 
surgery mouse surgery is a technique
used<00:02:04.200> to<00:02:04.469> remove<00:02:04.710> the<00:02:04.860> cancer<00:02:05.219> with<00:02:05.399> the<00:02:05.490> least

00:02:05.660 --> 00:02:05.670 
used to remove the cancer with the least

00:02:05.670 --> 00:02:07.069 
used to remove the cancer with the least
amount<00:02:05.909> of<00:02:06.060> surrounding<00:02:06.570> tissue<00:02:06.810> and<00:02:07.020> the

00:02:07.069 --> 00:02:07.079 
amount of surrounding tissue and the

00:02:07.079 --> 00:02:08.869 
amount of surrounding tissue and the
edges<00:02:07.380> are<00:02:07.560> checked<00:02:08.009> immediately<00:02:08.129> to<00:02:08.640> see<00:02:08.789> if

00:02:08.869 --> 00:02:08.879 
edges are checked immediately to see if

00:02:08.879 --> 00:02:11.150 
edges are checked immediately to see if
tumor<00:02:09.239> is<00:02:09.390> found<00:02:09.720> this<00:02:10.530> provides<00:02:10.979> the

00:02:11.150 --> 00:02:11.160 
tumor is found this provides the

00:02:11.160 --> 00:02:12.890 
tumor is found this provides the
opportunity<00:02:11.819> to<00:02:11.970> remove<00:02:12.300> the<00:02:12.450> least<00:02:12.660> amount

00:02:12.890 --> 00:02:12.900 
opportunity to remove the least amount

00:02:12.900 --> 00:02:13.700 
opportunity to remove the least amount
of<00:02:13.050> tissue

00:02:13.700 --> 00:02:13.710 
of tissue

00:02:13.710 --> 00:02:15.530 
of tissue
provide<00:02:14.070> the<00:02:14.220> best<00:02:14.400> cosmetically<00:02:15.000> favorable

00:02:15.530 --> 00:02:15.540 
provide the best cosmetically favorable

00:02:15.540 --> 00:02:18.200 
provide the best cosmetically favorable
results<00:02:15.990> this<00:02:16.710> is<00:02:16.980> especially<00:02:17.340> important<00:02:18.060> for

00:02:18.200 --> 00:02:18.210 
results this is especially important for

00:02:18.210 --> 00:02:20.270 
results this is especially important for
areas<00:02:18.510> where<00:02:18.690> excess<00:02:19.050> skin<00:02:19.200> is<00:02:19.500> limited<00:02:19.920> such

00:02:20.270 --> 00:02:20.280 
areas where excess skin is limited such

00:02:20.280 --> 00:02:22.730 
areas where excess skin is limited such
as<00:02:20.430> the<00:02:20.580> face<00:02:20.820> cure<00:02:21.780> rates<00:02:22.080> are<00:02:22.230> equivalent<00:02:22.710> to

00:02:22.730 --> 00:02:22.740 
as the face cure rates are equivalent to

00:02:22.740 --> 00:02:25.220 
as the face cure rates are equivalent to
white<00:02:22.980> excision<00:02:23.480> special<00:02:24.480> training<00:02:25.050> is

00:02:25.220 --> 00:02:25.230 
white excision special training is

00:02:25.230 --> 00:02:26.930 
white excision special training is
required<00:02:25.380> to<00:02:25.800> perform<00:02:26.010> this<00:02:26.340> technique<00:02:26.580> an

00:02:26.930 --> 00:02:26.940 
required to perform this technique an

00:02:26.940 --> 00:02:29.990 
required to perform this technique an
alternative<00:02:27.930> method<00:02:28.110> is<00:02:28.350> ccp<00:02:28.890> DNA<00:02:29.340> and<00:02:29.610> can<00:02:29.910> be

00:02:29.990 --> 00:02:30.000 
alternative method is ccp DNA and can be

00:02:30.000 --> 00:02:31.820 
alternative method is ccp DNA and can be
performed<00:02:30.240> by<00:02:30.630> pathologists<00:02:30.990> not<00:02:31.500> familiar

00:02:31.820 --> 00:02:31.830 
performed by pathologists not familiar

00:02:31.830 --> 00:02:34.130 
performed by pathologists not familiar
with<00:02:32.040> loss<00:02:32.220> surgery<00:02:32.790> in<00:02:33.000> the<00:02:33.420> case<00:02:33.630> of<00:02:33.840> disease

00:02:34.130 --> 00:02:34.140 
with loss surgery in the case of disease

00:02:34.140 --> 00:02:36.410 
with loss surgery in the case of disease
that<00:02:34.290> has<00:02:34.440> spread<00:02:34.910> metastasized<00:02:35.910> further

00:02:36.410 --> 00:02:36.420 
that has spread metastasized further

00:02:36.420 --> 00:02:38.690 
that has spread metastasized further
surgical<00:02:37.020> procedures<00:02:37.530> or<00:02:37.800> chemotherapy<00:02:38.610> may

00:02:38.690 --> 00:02:38.700 
surgical procedures or chemotherapy may

00:02:38.700 --> 00:02:41.000 
surgical procedures or chemotherapy may
be<00:02:38.880> required<00:02:39.270> skin<00:02:40.020> cancer<00:02:40.440> is<00:02:40.560> a<00:02:40.590> common

00:02:41.000 --> 00:02:41.010 
be required skin cancer is a common

00:02:41.010 --> 00:02:43.040 
be required skin cancer is a common
disease<00:02:41.310> yet<00:02:41.820> every<00:02:42.090> individual<00:02:42.660> needs

00:02:43.040 --> 00:02:43.050 
disease yet every individual needs

00:02:43.050 --> 00:02:45.440 
disease yet every individual needs
unique<00:02:43.350> treatment<00:02:43.800> and<00:02:43.950> care<00:02:44.310> we<00:02:45.090> encourage

00:02:45.440 --> 00:02:45.450 
unique treatment and care we encourage

00:02:45.450 --> 00:02:47.390 
unique treatment and care we encourage
people<00:02:45.660> with<00:02:46.200> skin<00:02:46.560> cancer<00:02:46.950> and<00:02:47.100> their

00:02:47.390 --> 00:02:47.400 
people with skin cancer and their

00:02:47.400 --> 00:02:49.100 
people with skin cancer and their
families<00:02:47.760> to<00:02:47.790> learn<00:02:48.060> as<00:02:48.330> much<00:02:48.720> as<00:02:48.870> possible

00:02:49.100 --> 00:02:49.110 
families to learn as much as possible

00:02:49.110 --> 00:02:51.200 
families to learn as much as possible
about<00:02:49.560> the<00:02:49.800> latest<00:02:50.100> medical<00:02:50.400> treatment<00:02:51.060> and

00:02:51.200 --> 00:02:51.210 
about the latest medical treatment and

00:02:51.210 --> 00:02:53.540 
about the latest medical treatment and
approaches<00:02:52.020> as<00:02:52.170> well<00:02:52.560> as<00:02:52.710> healthy<00:02:53.070> lifestyle

00:02:53.540 --> 00:02:53.550 
approaches as well as healthy lifestyle

00:02:53.550 --> 00:02:56.090 
approaches as well as healthy lifestyle
choices<00:02:53.900> for<00:02:54.900> more<00:02:55.050> information<00:02:55.590> about<00:02:55.710> skin

00:02:56.090 --> 00:02:56.100 
choices for more information about skin

00:02:56.100 --> 00:02:59.030 
choices for more information about skin
cancer<00:02:56.520> and<00:02:56.670> how<00:02:57.090> to<00:02:57.570> treat<00:02:57.810> skin<00:02:58.140> cancer<00:02:58.560> just

00:02:59.030 --> 00:02:59.040 
cancer and how to treat skin cancer just

00:02:59.040 --> 00:03:01.220 
cancer and how to treat skin cancer just
click<00:02:59.280> on<00:02:59.400> the<00:02:59.490> link<00:02:59.730> at<00:02:59.880> description<00:03:00.230> or

00:03:01.220 --> 00:03:01.230 
click on the link at description or

00:03:01.230 --> 00:03:06.620 
click on the link at description or
visit<00:03:03.620> www.imtcva.org

